Intelligent Bio Solutions Inc.
INBSNasdaqCIK 1725430HealthcareFiscal year ends Jun 30
Reports and events: 228 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2121:00 ET | 10-K/A | Annual report, amendedPeriod 2026-06-30 | 0001493152-26-047925 |
| 2026-10-1321:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-046863 |
| 2026-09-1121:00 ET | 8-K | 8.01 Other events | 0001493152-26-042411 |
| 2026-09-0912:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041901 |
| 2026-09-0221:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041253 |
| 2026-09-0121:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041055 |
| 2026-08-2821:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-040656 |
| 2026-08-1912:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-039140 |
| 2026-08-1912:30 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001493152-26-039136 |
| 2026-08-1121:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037206 |
| 2026-08-0512:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036112 |
| 2026-08-0321:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035861 |
| 2026-08-0321:20 ET | 8-K | 8.01 Other events | 0001493152-26-035860 |
| 2026-07-2321:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034428 |
| 2026-07-2112:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034018 |
| 2026-06-1620:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028898 |
| 2026-06-0212:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026780 |
| 2026-05-1401:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022823 |
| 2026-05-1312:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022617 |
| 2026-04-2012:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018002 |
| 2026-03-2320:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012173 |
| 2026-02-2514:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007973 |
| 2026-02-1213:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-006317 |
| 2026-02-1213:31 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001493152-26-006311 |
| 2026-02-0513:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-005210 |
| 2026-01-2822:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-004068 |
| 2026-01-0822:00 ET | 8-K | 8.01 Other events | 0001493152-26-000984 |
| 2026-01-0222:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-000176 |
| 2025-12-3121:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-029812 |
| 2025-12-1622:15 ET | 8-K | 3.01 Delisting notice | 0001493152-25-028003 |
| 2025-12-1222:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-027534 |
| 2025-12-0213:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025665 |
| 2025-11-2822:00 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-25-025410 |
| 2025-11-1222:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022005 |
| 2025-11-1213:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021751 |
| 2025-11-0722:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021323 |
| 2025-10-3021:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020262 |
| 2025-10-2120:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-018806 |
| 2025-09-2612:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-015068 |
| 2025-09-2521:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-014961 |
| 2025-09-1920:05 ET | DEF 14A | Proxy statementPeriod 2025-09-19 | 0001493152-25-014245 |
| 2025-09-1712:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013836 |
| 2025-08-1521:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-012101 |
| 2025-08-1512:31 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001641172-25-024279 |
| 2025-08-0721:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011706 |
| 2025-08-0613:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011634 |
| 2025-07-2821:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021200 |
| 2025-07-2321:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-020729 |
| 2025-07-1621:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011264 |
| 2025-07-1521:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019745 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.